Abstract
Background and aim
Arthroplasty registries and consecutive series indicate significantly worse results of conventional metal-on-polyethylene total hip arthroplasty (THA) in patients younger than 50 years compared to older patients, with inferior clinical outcomes and 10-year survivorship ranging between 70 and 90%. At our institution, patients under 50 needing a THA receive either a metal-on-metal hip resurfacing (MoMHRA) or a ceramic-on-ceramic (CoC)THA. In order to evaluate the outcome of these options at minimum 10 years, we conducted a retrospective review of all MoMHRA and CoCTHA with more than 10 years follow-up implanted in patients under 50.
Methods
From a single surgeon patients’ prospective database, we identified all consecutive THA performed before May 2005 in patients under 50. All patients are contacted by phone and asked to present for a clinical exam and patient reported outcome questionnaires, standard radiographs and metal ion measurements unless the hip arthroplasty has been revised. Complications and reasons for revision are noted. Kaplan-Meier survivorship is analysed for the whole cohort and sub-analysis is performed by type hip arthroplasty, gender, diagnosis and component size.
Results
We identified 773 hip arthroplasties in 684 patients under 50 years performed by a single surgeon between 1997 and May 2005. There are 626 MoMHRA, all Birmingham Hip Resurfacings (BHR) in 561 patients (65 bilateral BHR), 135 CoCTHA in 111 patients (24 bilateral CoC) and 12 Metasul MoMTHA in 12 patients. In the BHR group, there are 392 males (70%) (42 bilateral) and 169 females (30%) (23 bilateral). Mean age at surgery was 40.8 years (median 42 years; range 16–50 years). In 33 cases, a BHR dysplasia cup was used (23 in females). Mean follow-up is 11.5 years (median 11 years; range 10–17 years). In the Metasul MoMTHA, there are 8 males and 4 females. Mean age at surgery was 40.4 years (range 20–50 years). All THA were non-cemented and head size was 28mm in all cases. Mean follow-up is 16.8 years (median 17.5 years; range 12–19 years). In the CoCTHA group, there are 71 males (64%) (17 bilateral) and 40 females (36%) (7 bilateral). Mean age at surgery was 38.2 years (median 39 years; range 16–50 years). In 21 cases, the CoCTHA was a revision of a former hip replacement: 15 THA revisions and 6 hip resurfacing revisions. Three types non-cemented acetabular components were used and 7 types femoral stems (5 non-cemented; 2 cemented). Ceramic heads and inlays were Biolox forte in 128 cases and Biolox delta in 7. Head size was 28mm in 125, 32mm in 7 and 36mm in 3. Mean follow-up is 14.9 years (median 15 years; range 10–18 years).
Discussion
Patients under 50 needing a hip arthroplasty often present with more complex anatomic abnormalities or bone damage as in congenital dysplasia, avascular necrosis, traumatic osteoarthritis or rheumatic diseases. Besides, the worse results with conventional THA in young patients may be related to a higher activity level. We present the outcome and survivorship of MoMHRA and CoCTHA in patients under 50 at more than 10 years postop.
